Tratamento endovascular para trombose venosa profunda
Main Article Content
Abstract
A trombose venosa profunda (TVP) e a embolia pulmonar (EP), associados ou não, caracterizam o tromboembolismo venoso (TEV), condição que afeta aproximadamente 1 em cada 1000 pacientes por ano, causa mais de 100.000 mortes por ano nos EUA e é a causa de óbito evitável mais comum em pacientes hospitalizados nos EUA.
Article Details
Authors maintain copyright and grant the HSJ the right to first publication. From 2024, the publications wiil be licensed under Attribution 4.0 International , allowing their sharing, recognizing the authorship and initial publication in this journal.
Authors are authorized to assume additional contracts separately for the non-exclusive distribution of the version of the work published in this journal (e.g., publishing in an institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
Authors are encouraged to publish and distribute their work online (e.g., in institutional repositories or on their personal page) at any point after the editorial process.
Also, the AUTHOR is informed and consents that the HSJ can incorporate his article into existing or future scientific databases and indexers, under the conditions defined by the latter at all times, which will involve, at least, the possibility that the holders of these databases can perform the following actions on the article.